A sacrifice for others? Ethical dilemmas surrounding the UK randomised trial for the management of screen-detected ductal carcinoma in situ of the breast.
Asymptomatic ductal carcinoma in situ (DCIS) is a noninvasive breast lesion for which an effective treatment has yet to be ascertained. Women diagnosed with DCIS are therefore given the choice of either participating in a trial or choosing their own treatment. This raises a series of ethical dilemmas for both the patient and community health team.
H
H
Thornton
D001943:Breast Neoplasms / Q000175:diagnosis*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000175:diagnosis*; D004993:Ethics, Nursing; D005260:Female; D006801:Humans; D033281:Nontherapeutic Human Experimentation; D035844:Researcher-Subject Relations; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation